A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study

Clinical trial NCT05130437 · RECRUITING

Trial details

NCT number: NCT05130437
Sponsor: ModernaTX, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Propionic Acidemia

Start date: 2021-11-09
Primary completion: 2029-12-04
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.